Sự phân bổ của Annexin A1 và sự liên quan của nó đến ung thư

Perretti, 2004, Annexin 1 and neutrophil apoptosis, Biochem. Soc. Trans., 32, 507, 10.1042/bst0320507

Perretti, 2009, Annexin A1 and glucocorticoids as effectors of the resolution of inflammation, Nat. Rev. Immunol., 9, 62, 10.1038/nri2470

Lim, 2007, Annexin 1: the new face of an old molecule, FASEB J., 21, 968, 10.1096/fj.06-7464rev

Guo, 2013, Potential role of Anxa1 in cancer, Future Oncol., 9, 1773, 10.2217/fon.13.114

Biaoxue, 2014, Annexin A1 in malignant tumors: current opinions and controversies, Int. J. Biol. Markers, 29, e8, 10.5301/jbm.5000046

Raynal, 1994, Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins, Biochim. Biophys. Acta, 1197, 63, 10.1016/0304-4157(94)90019-1

Peers, 1993, Glucocorticoid-and non-glucocorticoid induction of lipocortins (annexins) 1 and 2 in rat peritoneal leucocytes in vivo, Br. J. Pharmacol., 108, 66, 10.1111/j.1476-5381.1993.tb13441.x

Perretti, 2000, Annexin I is stored within gelatinase granules of human neutrophil and mobilized on the cell surface upon adhesion but not phagocytosis, Cell Biol. Int., 24, 163, 10.1006/cbir.1999.0468

Walther, 2000, A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR, Mol. Cell, 5, 831, 10.1016/S1097-2765(00)80323-8

John, 2008, Annexin A1 and the formyl peptide receptor family: neuroendocrine and metabolic aspects, Curr. Opin. Pharmacol., 8, 765, 10.1016/j.coph.2008.09.005

Bizzarro, 2012, Annexin A1: novel roles in skeletal muscle biology, J. Cell Physiol., 227, 3007, 10.1002/jcp.24032

Ye, 2009, International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family, Pharmacol. Rev., 61, 119, 10.1124/pr.109.001578

Hall, 1993, Mass spectrometric and Edman sequencing of lipocortin I isolated by two-dimensional SDS/PAGE of human melanoma lysates, Proc. Natl. Acad. Sci. U.S.A., 90, 1927, 10.1073/pnas.90.5.1927

Rosengarth, 2003, A calcium-driven conformational switch of the N-terminal and core domains of annexin A1, J. Mol. Biol., 326, 1317, 10.1016/S0022-2836(03)00027-5

Rosengarth, 2001, X-ray structure of full-length annexin 1 and implications for membrane aggregation, J. Mol. Biol., 306, 489, 10.1006/jmbi.2000.4423

Glenney, 1985, Amino-terminal sequence of p36 and associated p10: identification of the site of tyrosine phosphorylation and homology with S-100, Proc. Natl. Acad. Sci. U.S.A., 82, 7884, 10.1073/pnas.82.23.7884

Johnsson, 1986, Functionally distinct serine phosphorylation sites of p36, the cellular substrate of retroviral protein kinase; differential inhibition of reassociation with p11, EMBO J., 5, 3455, 10.1002/j.1460-2075.1986.tb04669.x

Rosengarth, 1998, Ca2+-independent interaction of annexin I with phospholipid monolayers, FEBS Lett., 438, 279, 10.1016/S0014-5793(98)01318-0

Browning, 1990, Studies on the structural properties of lipocortin-1 and the regulation of its synthesis by steroids, Prog. Clin. Biol. Res., 349, 27

Gerke, 2002, Annexins: from structure to function, Physiol. Rev., 82, 331, 10.1152/physrev.00030.2001

Moss, 2004, The annexins, Genome Biol., 5, 219, 10.1186/gb-2004-5-4-219

Gerke, 2005, Annexins: linking Ca2+ signalling to membrane dynamics, Nat. Rev. Mol. Cell Biol., 6, 449, 10.1038/nrm1661

Burke, 2009, Phospholipase A2 structure/function, mechanism, and signaling, J. Lipid Res., 50, S237, 10.1194/jlr.R800033-JLR200

Ghosh, 2006, Properties of the group IV phospholipase A2 family, Prog. Lipid Res., 45, 487, 10.1016/j.plipres.2006.05.003

Nakanishi, 2006, Roles of cPLA2alpha and arachidonic acid in cancer, Biochim. Biophys. Acta, 1761, 1335, 10.1016/j.bbalip.2006.09.005

Leslie, 2015, Cytosolic phospholipase A2: physiological function and role in disease, J. Lipid Res., 56, 1386, 10.1194/jlr.R057588

Yarla, 2015, Phospholipase A2 isoforms as novel targets for prevention and treatment of inflammatory and oncologic diseases, Curr. Drug Targets

Parente, 2004, Annexin 1: more than an anti-phospholipase protein, Inflamm. Res., 53, 125, 10.1007/s00011-003-1235-z

Kim, 2001, Inhibition of cytosolic phospholipase A2 by annexin I. Specific interaction model and mapping of the interaction site, J. Biol. Chem., 276, 15712, 10.1074/jbc.M009905200

Kwon, 2012, Regulation of cytosolic phospholipase A2 phosphorylation by proteolytic cleavage of annexin A1 in activated mast cells, J. Immunol., 188, 5665, 10.4049/jimmunol.1102306

Qiu, 1998, The role of calcium and phosphorylation of cytosolic phospholipase A2 in regulating arachidonic acid release in macrophages, J. Biol. Chem., 273, 8203, 10.1074/jbc.273.14.8203

Sakaguchi, 2011, S100A11, a dual growth regulator of epidermal keratinocytes, Amino Acids, 41, 797, 10.1007/s00726-010-0747-4

He, 2009, S100A11: diverse function and pathology corresponding to different target proteins, Cell Biochem. Biophys., 55, 117, 10.1007/s12013-009-9061-8

Santamaria-Kisiel, 2006, Calcium-dependent and -independent interactions of the S100 protein family, Biochem. J., 396, 201, 10.1042/BJ20060195

Mailliard, 1996, Calcium-dependent binding of S100C to the N-terminal domain of annexin I, J. Biol. Chem., 271, 719, 10.1074/jbc.271.2.719

Rety, 2000, Structural basis of the Ca2+-dependent association between S100C (S100A11) and its target, the N-terminal part of annexin I, Structure, 8, 175, 10.1016/S0969-2126(00)00093-9

Poeter, 2013, Disruption of the annexin A1/S100A11 complex increases the migration and clonogenic growth by dysregulating epithelial growth factor (EGF) signaling, Biochim. Biophys. Acta, 1833, 1700, 10.1016/j.bbamcr.2012.12.006

White, 2006, EGF stimulates annexin 1-dependent inward vesiculation in a multivesicular endosome subpopulation, EMBO J., 25, 1, 10.1038/sj.emboj.7600759

Jaiswal, 2015, S100 and annexin proteins identify cell membrane damage as the Achilles heel of metastatic cancer cells, Cell Cycle, 14, 502, 10.1080/15384101.2014.995495

Hannon, 2003, Aberrant inflammation and resistance to glucocorticoids in annexin 1−/− mouse, FASEB J., 17, 253, 10.1096/fj.02-0239fje

Chiang, 2006, The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo, Pharmacol. Rev., 58, 463, 10.1124/pr.58.3.4

Li, 2013, Molecular biology for formyl peptide receptors in human diseases, J. Mol. Med. (Berl.), 91, 781, 10.1007/s00109-013-1005-5

Schiffmann, 1975, N-formylmethionyl peptides as chemoattractants for leucocytes, Proc. Natl. Acad. Sci. U.S.A., 72, 1059, 10.1073/pnas.72.3.1059

Marasco, 1984, Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli, J. Biol. Chem., 259, 5430, 10.1016/S0021-9258(18)91029-X

Dalpiaz, 2003, Studies on human neutrophil biological functions by means of formyl-peptide receptor agonists and antagonists, Curr. Drug Targets Immune Endocr. Metabol. Disord., 3, 33, 10.2174/1568008033340333

Gavins, 2014, Annexin A1 and the regulation of innate and adaptive immunity, Front. Immunol., 3, 354

Cooray, 2014, Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses, Proc. Natl. Acad. Sci. U.S.A., 110, 18232, 10.1073/pnas.1308253110

Lacy, 1995, Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia, J. Neuroimmunol., 61, 71, 10.1016/0165-5728(95)00075-D

VanCompernolle, 2003, Expression and function of formyl peptide receptors on human fibroblast cells, J. Immunol., 171, 2050, 10.4049/jimmunol.171.4.2050

Li, 2008, Formyl-peptide receptor like 1: a potent mediator of the Ca2+ release-activated Ca2+ current ICRAC, Arch. Biochem. Biophys., 478, 110, 10.1016/j.abb.2008.07.002

Li, 2011, Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2, Oncogene, 30, 3887, 10.1038/onc.2011.112

Diakonova, 1997, Localization of five annexins in J774 macrophages and on isolated phagosomes, J. Cell Sci., 110, 1199, 10.1242/jcs.110.10.1199

Rescher, 2000, Intact Ca2+-binding sites are required for targeting of annexin 1 to endosomal membranes in living HeLa cells, J. Cell Sci., 113, 3931, 10.1242/jcs.113.22.3931

Futter, 2007, Annexins and endocytosis, Traffic, 8, 951, 10.1111/j.1600-0854.2007.00590.x

Mussunoor, 2008, The role of annexins in tumour development and progression, J. Pathol., 216, 131, 10.1002/path.2400

de Graauw, 2010, Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells, Proc. Natl. Acad. Sci. U.S.A., 107, 6340, 10.1073/pnas.0913360107

Hayes, 2002, TGF beta receptor internalization into EEA1-enriched early endosomes: role in signaling to Smad2, J. Cell Biol., 158, 1239, 10.1083/jcb.200204088

Chen, 2009, Endocytic regulation of TGF-beta signaling, Cell Res., 19, 58, 10.1038/cr.2008.315

Wos, 2014, [Participation of annexins in endocytosis and EGFR-mediated signal transduction], Postepy Biochem., 60, 55

Bist, 2011, Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-kappaB: implication in breast cancer metastasis, Oncogene, 30, 3174, 10.1038/onc.2011.28

Anbalagan, 2014, Annexin-A1 regulates microRNA-26b* and microRNA-562 to directly target NF-kappaB and angiogenesis in breast cancer cells, PLoS One, 9, e114507, 10.1371/journal.pone.0114507

Kang, 2012, The role of annexin A1 in expression of matrix metalloproteinase-9 and invasion of breast cancer cells, Biochem. Biophys. Res. Commun., 423, 188, 10.1016/j.bbrc.2012.05.114

Sakaguchi, 2007, Truncation of annexin A1 is a regulatory lever for linking epidermal growth factor signaling with cytosolic phospholipase A2 in normal and malignant squamous epithelial cells, J. Biol. Chem., 282, 35679, 10.1074/jbc.M707538200

Han, 2014, Association of nuclear annexin A1 with prognosis of patients with esophageal squamous cell carcinoma, Int. J. Clin. Exp. Pathol., 7, 751

Zhu, 2010, Nuclear localization of annexin A1 correlates with advanced disease and peritoneal dissemination in patients with gastric carcinoma, Anat. Rec. (Hoboken), 293, 1310, 10.1002/ar.21176

Rhee, 2000, Annexin I is a stress protein induced by heat, oxidative stress and a sulfhydryl-reactive agent, Eur. J. Biochem., 267, 3220, 10.1046/j.1432-1327.2000.01345.x

Kim, 2003, PKCdelta-dependent cleavage and nuclear translocation of annexin A1 by phorbol 12-myristate 13-acetate, Eur. J. Biochem., 270, 4089, 10.1046/j.1432-1033.2003.03800.x

Hoque, 2014, Annexins - Scaffolds modulating PKC localization and signaling, Cell Signal., 26, 1213, 10.1016/j.cellsig.2014.02.012

Hirata, 2010, Ubiquitination and SUMOylation of annexin A1 and helicase activity, Biochim. Biophys. Acta, 1800, 899, 10.1016/j.bbagen.2010.03.020

Caron, 2013, Annexin A1 is regulated by domains cross-talk through post-translational phosphorylation and SUMOYlation, Cell Signal., 25, 1962, 10.1016/j.cellsig.2013.05.028

Lin, 2008, Nuclear localization of annexin A1 is a prognostic factor in oral squamous cell carcinoma, J. Surg. Oncol., 97, 544, 10.1002/jso.20992

Liu, 2003, Translocation of annexin I from cellular membrane to the nuclear membrane in human esophageal squamous cell carcinoma, World J. Gastroenterol., 9, 645, 10.3748/wjg.v9.i4.645

Hirata, 1999, Lipocortin (Annexin) I heterotetramer binds to purine RNA and pyrimidine DNA, Biochem. Biophys. Res. Commun., 265, 200, 10.1006/bbrc.1999.1660

Hirata, 2002, DNA chain unwinding and annealing reactions of lipocortin (annexin) I heterotetramer: regulation by Ca2+ and Mg2+, Biochem. Biophys. Res. Commun., 291, 205, 10.1006/bbrc.2002.6422

Lin, 1997, The biochemical status of the DNA synthesome can distinguish between permanent and temporary cell growth arrest, Cell Growth Differ., 8, 1359

Kunkel, 1999, The high cost of living. American Association for Cancer Research Special Conference: endogenous sources of mutations, Fort Myers, Florida, USA, 11–15 November 1998, Trends Genet., 15, 93, 10.1016/S0168-9525(98)01664-3

Kunz, 2000, DNA damage-induced mutation: tolerance via translesion synthesis, Mutat. Res., 451, 169, 10.1016/S0027-5107(00)00048-8

Makridakis, 2012, Translesion DNA polymerases and cancer, Front. Genet., 3, 174, 10.3389/fgene.2012.00174

Dieckman, 2012, PCNA structure and function: insights from structures of PCNA complexes and post-translationally modified PCNA, Subcell. Biochem., 62, 281, 10.1007/978-94-007-4572-8

Ulrich, 2005, The RAD6 pathway: control of DNA damage bypass and mutagenesis by ubiquitin and SUMO, Chembiochemistry, 6, 1735, 10.1002/cbic.200500139

Hirata, 2011, Carcinogenic heavy metals, As3+ and Cr6+, increase affinity of nuclear mono-ubiquitinated annexin A1 for DNA containing 8-oxo-guanosine, and promote translesion DNA synthesis, Toxicol. Appl. Pharmacol., 252, 159, 10.1016/j.taap.2011.01.022

Maier, 2002, Arsenic co-exposure potentiates benzo[a]pyrene genotoxicity, Mutat. Res., 517, 101, 10.1016/S1383-5718(02)00057-8

Hirata, 2014, Dietary flavonoids bind to mono-ubiquitinated annexin A1 in nuclei, and inhibit chemical induced mutagenesis, Mutat Res. Fundam. Mol. Mech. Mutagen, 759, 29, 10.1016/j.mrfmmm.2013.11.002

Gerdes, 2008, Membrane traffic in the secretory pathway, Cell. Mol. Life Sci., 65, 2779, 10.1007/s00018-008-8348-z

Wallner, 1986, Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity, Nature, 320, 77, 10.1038/320077a0

Philip, 1998, Blockade of the classical pathway of protein secretion does not affect the cellular exportation of lipocortin 1, Regul. Pept., 73, 133, 10.1016/S0167-0115(97)01077-X

Christmas, 1991, Selective secretion of annexin 1, a protein without a signal sequence, by the human prostate gland, J. Biol. Chem., 266, 2499, 10.1016/S0021-9258(18)52272-9

Vong, 2007, Annexin 1 cleavage in activated neutrophils: a pivotal role for proteinase 3, J. Biol. Chem., 282, 29998, 10.1074/jbc.M702876200

Boudhraa, 2014, Characterization of pro-invasive mechanisms and N-terminal cleavage of ANXA1 in melanoma, Arch Dermatol. Res., 306, 903, 10.1007/s00403-014-1517-z

Solito, 2006, Post-translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface, FASEB J., 20, 1498, 10.1096/fj.05-5319fje

Aderem, 1988, Stimulus-dependent myristoylation of a major substrate for protein kinase C, Nature, 332, 362, 10.1038/332362a0

Wein, 2004, Mediation of annexin 1 secretion by a probenecid-sensitive ABC-transporter in rat inflamed mucosa, Biochem. Pharmacol., 67, 1195, 10.1016/j.bcp.2003.11.015

Omer, 2006, Evidence for the role of adenosine 5′-triphosphate-binding cassette (ABC)-A1 in the externalization of annexin 1 from pituitary folliculostellate cells and ABCA1-transfected cell models, Endocrinology, 147, 3219, 10.1210/en.2006-0099

Euzger, 1999, Differential modulation of annexin I binding sites on monocytes and neutrophils, Mediators Inflamm., 8, 53, 10.1080/09629359990720

Goulding, 1996, Evidence for specific annexin I-binding proteins on human monocytes, Biochem. J., 316, 593, 10.1042/bj3160593

Sadallah, 2011, Ectosomes as modulators of inflammation and immunity, Clin. Exp. Immunol., 163, 26, 10.1111/j.1365-2249.2010.04271.x

Distler, 2005, Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases, Arthritis Rheum., 52, 3337, 10.1002/art.21350

Gasser, 2003, Characterisation and properties of ectosomes released by human polymorphonuclear neutrophils, Exp. Cell Res., 285, 243, 10.1016/S0014-4827(03)00055-7

Dalli, 2008, Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles, Blood, 112, 2512, 10.1182/blood-2008-02-140533

Tsai, 2012, Annexin A1 mediates the anti-inflammatory effects during the granulocytic differentiation process in all-trans retinoic acid-treated acute promyelocytic leukemic cells, J. Cell Physiol., 227, 3661, 10.1002/jcp.24073

Raposo, 2013, Extracellular vesicles: exosomes, microvesicles, and friends, J. Cell Biol., 200, 373, 10.1083/jcb.201211138

Aalberts, 2012, Identification of distinct populations of prostasomes that differentially express prostate stem cell antigen, annexin A1, and GLIPR2 in humans, Biol. Reprod., 86, 82, 10.1095/biolreprod.111.095760

Sakwe, 2011, Annexin A6 contributes to the invasiveness of breast carcinoma cells by influencing the organization and localization of functional focal adhesions, Exp. Cell Res., 317, 823, 10.1016/j.yexcr.2010.12.008

Williams, 2010, A proinflammatory role for proteolytically cleaved annexin A1 in neutrophil transendothelial migration, J. Immunol., 185, 3057, 10.4049/jimmunol.1000119

Blume, 2012, Cleavage of annexin A1 by ADAM10 during secondary necrosis generates a monocytic ‘find-me’ signal, J. Immunol., 188, 135, 10.4049/jimmunol.1004073

Woloszynek, 2012, Cathepsin G-regulated release of formyl peptide receptor agonists modulate neutrophil effector functions, J. Biol. Chem., 287, 34101, 10.1074/jbc.M112.394452

Pederzoli-Ribeil, 2010, Design and characterization of a cleavage-resistant Annexin A1 mutant to control inflammation in the microvasculature, Blood, 116, 4288, 10.1182/blood-2010-02-270520

Dalli, 2013, Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor, J. Immunol., 190, 6478, 10.4049/jimmunol.1203000

Fu, 2006, Ligand recognition and activation of formyl peptide receptors in neutrophils, J. Leukoc. Biol., 79, 247, 10.1189/jlb.0905498

Blume, 2009, Cell surface externalization of annexin A1 as a failsafe mechanism preventing inflammatory responses during secondary necrosis, J. Immunol., 183, 8138, 10.4049/jimmunol.0902250

Scannell, 2007, Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages, J. Immunol., 178, 4595, 10.4049/jimmunol.178.7.4595

Belvedere, 2014, Role of intracellular and extracellular annexin A1 in migration and invasion of human pancreatic carcinoma cells, BMC Cancer, 14, 961, 10.1186/1471-2407-14-961

Renshaw, 2010, Downstream gene activation of the receptor ALX by the agonist annexin A1, PLoS One, 5, 10.1371/journal.pone.0012771

Hayhoe, 2006, Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement, Blood, 107, 2123, 10.1182/blood-2005-08-3099

Liu, 2012, G protein-coupled receptor FPR1 as a pharmacologic target in inflammation and human glioblastoma, Int. Immunopharmacol., 14, 283, 10.1016/j.intimp.2012.07.015

Bizzarro, 2012, Annexin A1 induces skeletal muscle cell migration acting through formyl peptide receptors, PLoS One, 7, e48246, 10.1371/journal.pone.0048246

Cheng, 2012, Annexin A1 is associated with gastric cancer survival and promotes gastric cancer cell invasiveness through the formyl peptide receptor/extracellular signal-regulated kinase/integrin beta-1-binding protein 1 pathway, Cancer, 118, 5757, 10.1002/cncr.27565

Cheng, 2014, Formyl peptide receptor 1 expression is associated with tumor progression and survival in gastric cancer, Anticancer Res., 34, 2223

Yang, 2011, Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1, Am. J. Pathol., 179, 1504, 10.1016/j.ajpath.2011.05.059

D'Acquisto, 2013, Pro-inflammatory and pathogenic properties of Annexin-A1: the whole is greater than the sum of its parts, Biochem. Pharmacol., 85, 1213, 10.1016/j.bcp.2013.02.011

Yom, 2011, Clinical significance of annexin A1 expression in breast cancer, J. Breast Cancer, 14, 262, 10.4048/jbc.2011.14.4.262

Khau, 2011, Annexin-1 signals mitogen-stimulated breast tumor cell proliferation by activation of the formyl peptide receptors (FPRs) 1 and 2, FASEB J., 25, 483, 10.1096/fj.09-154096

Guenther, 2010, The bisphosphonate zoledronic acid has antimyeloma activity in vivo by inhibition of protein prenylation, Int. J. Cancer, 126, 239, 10.1002/ijc.24758

Yeganeh, 2014, Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease, Pharmacol. Ther., 143, 87, 10.1016/j.pharmthera.2014.02.007

Thurnher, 2012, Novel aspects of mevalonate pathway inhibitors as antitumor agents, Clin. Cancer Res., 18, 3524, 10.1158/1078-0432.CCR-12-0489

Milone, 2015, Proteomic analysis of zoledronic-acid resistant prostate cancer cells unveils novel pathways characterizing an invasive phenotype, Oncotarget, 6, 5324, 10.18632/oncotarget.2694

Bizzarro, 2015, Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid, Oncotarget, 6, 25076, 10.18632/oncotarget.4725

Zhou, 2005, Formylpeptide receptor FPR and the rapid growth of malignant human gliomas, J. Natl. Cancer Inst., 97, 823, 10.1093/jnci/dji142

Huang, 2010, The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells, Br. J. Cancer, 102, 1052, 10.1038/sj.bjc.6605591

Cheng, 2013, FoxM1 promotes glioma cells progression by up-regulating Anxa1 expression, PLoS One, 8, e72376, 10.1371/journal.pone.0072376

Boudhraa, 2014, Annexin A1 in primary tumors promotes melanoma dissemination, Clin. Exp. Metastasis, 31, 749, 10.1007/s10585-014-9665-2

Chakravarti, 2013, Differential expression of the G-protein-coupled formyl peptide receptor in melanoma associates with aggressive phenotype, Am. J. Dermatopathol., 35, 184, 10.1097/DAD.0b013e31825b2506

Su, 2010, Increased expression of annexin A1 is correlated with K-ras mutation in colorectal cancer, Tohoku J. Exp. Med., 222, 243, 10.1620/tjem.222.243

Hoffmann, 2010, Aberrant expression of alternative DNA polymerases: a source of mutator phenotype as well as replicative stress in cancer, Semin. Cancer Biol., 20, 312, 10.1016/j.semcancer.2010.10.001

Sinha, 1998, Increased expression of annexin I and thioredoxin detected by two-dimensional gel electrophoresis of drug resistant human stomach cancer cells, J. Biochem. Biophys. Methods, 37, 105, 10.1016/S0165-022X(98)00020-7

Sheu, 2014, Overexpression of ANXA1 confers independent negative prognostic impact in rectal cancers receiving concurrent chemoradiotherapy, Tumour Biol., 35, 7755, 10.1007/s13277-014-2032-8

Zhang, 2012, Cisplatin treatment leads to changes in nuclear protein and microRNA expression, Mutat. Res., 746, 66, 10.1016/j.mrgentox.2012.03.004

Wang, 2014, Regulatory mechanisms of annexin-induced chemotherapy resistance in cisplatin resistant lung adenocarcinoma, Asian Pac. J. Cancer Prev., 15, 3191, 10.7314/APJCP.2014.15.7.3191

Gandellini, 2015, Complexity in the tumour microenvironment: Cancer associated fibroblast gene expression patterns identify both common and unique features of tumour-stroma crosstalk across cancer types, Semin. Cancer Biol., 10.1016/j.semcancer.2015.08.008

Liotta, 2001, The microenvironment of the tumour–host interface, Nature, 411, 375, 10.1038/35077241

Liu, 2014, Formyl peptide receptor suppresses melanoma development and promotes NK cell migration, Inflammation, 37, 984, 10.1007/s10753-014-9819-z

Perretti, 2009, Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics, Br. J. Pharmacol., 158, 936, 10.1111/j.1476-5381.2009.00483.x

Yi, 2009, Impaired tumor growth, metastasis, angiogenesis and wound healing in annexin A1-null mice, Proc. Natl. Acad. Sci. U.S.A., 106, 17886, 10.1073/pnas.0901324106

Geary, 2014, CAF-secreted Annexin A1 induces prostate cancer cells to gain stem cell-like features, Mol. Cancer Res., 12, 607, 10.1158/1541-7786.MCR-13-0469

Echarri, 2015, Caveolae - mechanosensitive membrane invaginations linked to actin filaments, J. Cell Sci., 128, 2747, 10.1242/jcs.153940

Schnitzer, 1995, Endothelial caveolae have the molecular transport machinery for vesicle budding, docking, and fusion including VAMP, NSF, SNAP, annexins, and GTPases, J. Biol. Chem., 270, 14399, 10.1074/jbc.270.24.14399

Oh, 2007, Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung, Nat. Biotechnol., 25, 327, 10.1038/nbt1292

Oh, 2014, In vivo proteomic imaging analysis of caveolae reveals pumping system to penetrate solid tumors, Nat. Med., 20, 1062, 10.1038/nm.3623

Oh, 2004, Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy, Nature, 429, 629, 10.1038/nature02580